Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Sintayehu Kebede"'
Autor:
Chae Bok Lee, Hei Gwon Choi, Sintayehu Kebede Gurmessa, In-Taek Jang, Naresh Kumar, Zongyou Jiang, Nagendra Kumar Kaushik, Hwa-Jung Kim
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-16 (2024)
Abstract Background Recently, atmospheric non-thermal plasma jet-treated medium (PTM) has been recognized as a novel strategy in cancer therapy and lymphocyte activation. However, PTM has limitations in inducing a robust antitumor-immune response. Th
Externí odkaz:
https://doaj.org/article/105ff29454c14ba1a30ddffb468635ec
Autor:
Sintayehu Kebede
Publikováno v:
Archives of Civil Engineering, Vol vol. 68, Iss No 1, Pp 145-168 (2022)
Construction contracts are susceptible to disputes as they regulate very complex multi-party relationships. Previous studies not only fail to aptly outline the distinction between “conflict” and “dispute”, but also fail to adequately study th
Externí odkaz:
https://doaj.org/article/cb03782548b24eeb8f233e35dcf12def
Autor:
Chae Bok Lee, Kang In Lee, Young Jae Kim, In Taek Jang, Sintayehu Kebede Gurmessa, Eun Ha Choi, Nagendra Kumar Kaushik, Hwa-Jung Kim
Publikováno v:
Biomedicines, Vol 10, Iss 6, p 1243 (2022)
Plasma-treated media (PTM) serve as an adjuvant therapy to postoperatively remove residual cancerous lesions. We speculated that PTM could selectively kill cells infected with Mycobacterium tuberculosis (Mtb) and remove postoperative residual tubercu
Externí odkaz:
https://doaj.org/article/56502bd9c1dd4bb990863a8a0b219f9c
Autor:
Seunga Choi, Han-Gyu Choi, Yong Woo Back, Hye-Soo Park, Kang-In Lee, Sintayehu Kebede Gurmessa, Thuy An Pham, Hwa-Jung Kim
Publikováno v:
Biomolecules, Vol 11, Iss 9, p 1306 (2021)
The widely administered tuberculosis (TB) vaccine, Bacillus Calmette-Guerin (BCG), is the only licensed vaccine, but has highly variable efficiency against childhood and pulmonary TB. Therefore, the BCG prime-boost strategy is a rational solution for
Externí odkaz:
https://doaj.org/article/902cc30263ed4b4f99067d36769bda17
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Linh Nhat Nguyen, Liem Quang Nguyen, Nagendra Kumar Kaushik, Pradeep Bhartiya, Sintayehu Kebede Gurmessa, Hwa-Jung Kim, Neha Kaushik, Eun Ha Choi
Publikováno v:
Journal of Industrial and Engineering Chemistry. 100:99-111
The development of an efficient tumor-specific therapeutic approach, which functions against the primary tumor and also repairs the host immune system to eradicate distant tumors, remains a clinical issue. Herein, this study focuses on the use of pol
Autor:
Sintayehu Kebede Gurmessa, Thi Binh Dang, Seunga Choi, Han-Gyu Choi, Hwa-Jung Kim, Kang-In Lee, Yong Woo Back, Hye-Soo Park
Publikováno v:
Microbiology and Immunology. 65:178-188
Mycobacterium tuberculosis contains diverse immunologically active components. This study investigated the biological function of a newly identified component, Rv1654, with the potential to induce apoptosis in macrophages. Recombinant Rv1654 induced
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kim Young Mi, Jaebeom Lee, Hwa-Jung Kim, Jeonghyo Kim, Huu Quang Nguyen, Jeongkwon Kim, Van Tan Tran, Tae Jung Park, Tae Sun Shim, Lemma Teshome Tufa, Kang-In Lee, Sintayehu Kebede Gurmessa
Publikováno v:
ACS Applied Nano Materials. 4:539-549
The development of sensitive and point-of-care diagnostic tools for the serological profile of numerous Mycobacterium tuberculosis (MTB) rectifies the existing flaws in tuberculosis diagnosis. Here...
Autor:
Sintayehu Kebede Gurmessa, Yong Woo Back, Han-Gyu Choi, Hye-Soo Park, Seunga Choi, Kang-In Lee, Thuy An Pham, Hwa-Jung Kim
Publikováno v:
Biomolecules
Volume 11
Issue 9
Biomolecules, Vol 11, Iss 1306, p 1306 (2021)
Volume 11
Issue 9
Biomolecules, Vol 11, Iss 1306, p 1306 (2021)
The widely administered tuberculosis (TB) vaccine, Bacillus Calmette-Guerin (BCG), is the only licensed vaccine, but has highly variable efficiency against childhood and pulmonary TB. Therefore, the BCG prime-boost strategy is a rational solution for